5 takeaways from the abortion pill case before the U.S. Supreme Court
U.S. Supreme Court justices on Tuesday did not appear ready to limit Americansโ access to the abortion pill mifepristone, in a case that could have sweeping implications for how the federal government approves scores of medications.
Supreme Court again confronts the issue of abortion, this time over access to widely used medication
The Supreme Court is considering a new abortion case affecting women across the U.S. Abortion opponents want the high court in arguments Tuesday to ratify a ruling from a conservative federal appeals court that would limit access to a medication called mifepristone, which was used in nearly two-thirds of abortions last year.
Fast-food wrappers that contain PFAS are no longer sold in the US, the FDA says
Fast-food wrappers and packaging that contain so-called forever chemicals are no longer being sold in the U.S. The Food and Drug Administration says the voluntary effort that began in 2020 between the agency and U.S. food manufacturers has been completed.
Court revives doctors' lawsuit saying FDA overstepped its authority with anti-ivermectin campaign
A federal appeals court in New Orleans has revived a lawsuit by three doctors who say the Food and Drug Administration overstepped its authority in a campaign against the use of a drug that is not approved to treat COVID-19.
Cancer drugs shortage could delay when patients get life saving treatments
Two drugs for cancer patients are in short supply and that shortage could delay when patients can get life saving treatments. Two drugs cisplatin and carboplatin used to be as widely available as aspirin but now 70% to 90% of doctors in the country, that treat cancer, have reported difficulty getting the drugs for their patients.
New blood donation rules allow more gay men to give in US
New blood donations rules will allow sexually active gay and bisexual men in monogamous relationships to give in the U.S. The Food and Drug Administration guidelines ease decades-old restrictions on blood donations put in place to protect the blood supply from HIV.
Justice Department appeals Texas abortion pill order
The Justice Department is appealing a Texas court ruling that would halt approval of a drug used in the most common method of abortion in the U_S_ In its appeal Monday, the Justice Department called the decision โextraordinary and unprecedented.โ.
What does 1870s Comstock Act have to do with abortion pills?
A 19th century โanti-viceโ law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act is being been revived by groups seeking to block the mailing of mifepristone, the pill used in more than half of U.S. abortions.
Access to abortion pill in limbo after competing rulings
Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.
Panel backs moving opioid antidote Narcan over the counter
The Nonprescription Drugs Advisory Committee (NDAC) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is discussing supplemental new drug application 208411/Sโ006, for NARCAN (naloxone hydrochloride) nasal spray, submitted by Emergent BioSolutions Inc.
Abortion pill could be pulled off market by Texas lawsuit
A Texas lawsuit is posing a threat to the nationwide availability of medication abortion, which now accounts for the majority of abortions in the U.S. The case filed by abortion opponents who helped challenge Roe v. Wade seeks to reverse a decades-old approval by the Food and Drug Administration.
A panel of experts answer questions about the COVID-19 booster shot during an FDA meeting
How often should Americans get their booster shot against COVID-19, and how important is the booster to you if youโve already been infected with COVID-19? Those are questions a panel of experts set out to answer during an FDA meeting, the information will be passed on to the CDC.
Florida health agency issues notice to providers following FDA decision on mifepristone
The Food and Drug Administration recently made a regulatory change, paving the way for the sale of mifepristone at retail pharmacies โ and executives at Walgreens and CVS have both said they plan to carry it where itโs permitted.